Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 6;14:3984. doi: 10.1038/s41467-023-39674-0

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 3 — A Exposure (vaccination status) misclassification: comparison of vaccination dates in NIMS versus the questionnaire, by vaccination dose. B Outcome misclassification by symptomatic status: individuals reporting in the questionnaire they were symptomatic, by case and vaccination status. C Outcome misclassification by symptom onset date: comparison of onset dates in SGSS versus the questionnaire. D Deferral bias: individuals reporting they delayed their vaccination because they had COVID-19 or COVID-19 like symptoms, by length of vaccine delay from invitation. E Riskier behaviour after vaccination: individuals reporting they mixed more, the same or less after their vaccination, by vaccination dose. F Vaccination visit transit mode in relation to COVID-19: individuals reporting their mode of transport to the vaccination centre, amongst those with a positive COVID-19 test ≤2 weeks versus those with a positive COVID-19 test >2 weeks.